Related Experiment Videos
Beyond fast track for drug approvals
Thomas G Roberts1, Bruce A Chabner
1Division of Hematology-Oncology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA. troberts@partners.org
The New England Journal of Medicine
|July 30, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.
Breast cancer research and treatment·2021
Fibromyalgia.
The New England journal of medicine·2026
Health Care-Associated Infections in U.S. Hospitals, 2023 versus 2015.
The New England journal of medicine·2026
Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease.
The New England journal of medicine·2026
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma.
The New England journal of medicine·2026
Andes Virus - A Clinical Review.
The New England journal of medicine·2026
Platelet-Activating Anti-Platelet Factor 4 Disorders.
The New England journal of medicine·2026
Pooled analysis assessing the efficacy and safety of amphetamine derivative adjunctive therapy for bipolar depression.
Journal of affective disorders·2026
Naloxone receipt following non-fatal opioid poisoning among Medicaid beneficiaries.
Journal of the American Pharmacists Association : JAPhA·2026
Cardiovascular Drug Access in Australia and New Zealand: New PBS and PHARMAC Listings, 2023-2025.
Heart, lung & circulation·2026